News

Linkage Sells to Thermo Fisher

BroadOak Partners advises Linkage Biosciences on the sale of the company to Thermo Fisher Scientific. Linkage Biosciences is a provider of molecular diagnostic technologies that enable complex genetic testing for transplantation and transfusion applications.

View Press Release.

Trinean Sells to Unchained Labs

BroadOak Partners advises Trinean on the sale of the company to Unchained Labs. Trinean is a provider of instrumentation and analytical software that measures concentrations of protein, DNA, and RNA in biologic and genomic samples.

View Press Release.

LabConnect Announces $24.5 Million Financing Round

BroadOak Partners acted as the exclusive placement agent for LabConnect’s $24.5 million Series A financing round to fuel growth initiatives, including additional build-out of the technology platform, product and service enhancements, and sales team expansion, as well as to provide liquidity to early shareholders. The round included participation from ABS Capital Partners, a leading late-stage growth company investor, Pablo Capital, and an affiliate fund of BroadOak Capital.

View Press Release.

Rubicon Genomics Sells to Takara Bio

BroadOak Partners advises Rubicon Genomics on the sale of the company to Takara Bio. Rubicon Genomics is a provider high quality, nucleic acid library preparation and companion products for next-generation DNA sequencing.

View Press Release.

MTI-GlobalStem Sells to Thermo Fisher Scientific

BroadOak Partners advises MTI-GlobalStem on the sale of the company to Thermo Fisher Scientific Inc. MTI-GlobalStem is a provider of leading-edge technology and reagents for cell transfection, neurobiology and stem cell research applications.

View Press Release.

Brooks Automation Announces the Acquisition of Cool Lab, LLC

BioCision, LLC, a BroadOak portfolio company, has divested its Cool Lab subsidiary to Brooks Automation, Inc. (Nasdaq:BRKS). Cool Lab, LLC provides a range of innovative, patented, and/or patent-pending applications for sample cooling and freezing, controlled rate freezing, portable cryogenic transport and archival storage solutions for customers’ temperature sensitive workflows.

View Press Release.

BioCision Announces the Formation of MedCision

BroadOak portfolio company, BioCision, LLC announces the formation of MedCision Inc, an independent company focused on the automation of pre-clinical and clinical processes focused on the commercialization of the award-winning ThawStar® automated cell thawing platform.

View Press Release.

GTCR and Maravai Complete Acquisitions of TriLink Biotechnologies and Cygnus Technologies

BroadOak Partners advises Maravai LifeSciences, Inc., a partnership including GTCR, a leading private equity firm, on the acquisition of two Life Sciences companies to expand Maravai’s strategy in specialty research reagents and add a bioprocessing leader.

View Press Release.

Antibodies-online GmbH Raises Growth Capital

BroadOak provided growth capital financing to antibodies-online GmbH, a leading digital marketing and e-commerce platform for the distribution of life sciences research products, in order to support continued development of their e-commerce platform and their recent expansion into the genomics market through the launch of genomics-online.com.

View Press Release.

Bioo Scientific Sells to PerkinElmer

BroadOak Partners advises Bioo Scientific Corporation on the sale of the company to PerkinElmer, Inc. Bioo Scientific is a leading provider of food safety tests sold into food processing and animal feed markets, and next generation sequencing reagents sold into the life science research markets.

View Press Release.

Clarity Sells Ophthalmic Imaging Business to Natus Medical

BroadOak Partners advises Clarity Medical Systems, a leading provider of clinical ophthalmic technologies, on the sale of its RetCam Ophthalmic Imaging System business to Natus Medical, Inc.

View Press Release.

GTCR and Maravai Complete Strategic Equity Investment in Vector Laboratories

BroadOak Partners advises Maravai LifeSciences, Inc., a partnership including GTCR, a leading private equity firm, on a strategic equity investment in Vector Laboratories, Inc. a provider of life science products, including labeling and detection reagents, that help medical and scientific researchers visualize cells in experiments which are central to the understanding of cancer and other diseases.

View Press Release.

LabConnect Raises $4.0 million to Fund Growth Targets

The BroadOak Fund III has completed a $4.0 million investment into LabConnect, LLC, a leading global provider of central laboratory and support services for biopharmaceutical, medical device and contract research organizations.

View Press Release.

AdvanDx Sells to OpGen; OpGen Secures $6M in Financing from Merck GHI Fund

BroadOak Partners advises AdvanDx, a developer of rapid molecular tests for the diagnosis and treatment of life-threatening infections, to OpGen. As part of the transaction, OpGen also secured $6 million in financing from the Merck Global Health Innovation Fund (Merck GHI).

View Press Release.

Rubicon Genomics Raises $2m to Support Strong Growth Momentum

BroadOak Capital Partners led the round, joined by Research Corporation Technologies. The Ann Arbor, Michigan-based sample prep firm said it will use the proceeds to develop new and existing products, including its ThruPlex Plasma-seq liquid biopsy kit, and to add to its sales and marketing.

View Press Release.

Diagnostic Biosystems Raises Growth Capital to Support Continued Expansion

The BroadOak Fund, an affiliate of BroadOak Capital Partners, provided financing to Diagnostic Biosystems to support continued expansion and growth.

View Press Release.

Spectra Analysis Instruments, Inc. Sells to DANI Instruments Group

BroadOak Capital Partners, through its affiliate the BroadOak Fund, successfully exited its investment in Spectra Analysis Instruments, Inc. upon sale of the business to DANI Instruments Group.

View Press Release.

Orflo Closes Growth Capital Investment

BroadOak Capital Partners, through its affiliate the BroadOak Fund, lead a $3.0 million financing for Orflo Technologies, an innovator of cell analysis and flow cytometry solutions.

View Press Release.

BroadOak Fund Provides Acquisition Financing to BioInformatics

The BroadOak Fund, an affiliate of BroadOak Capital Partners, provided financing to BioInformatics for the acquisition of Strategic Directions International, Inc.

View Press Release.

Stemgent Sells iPS Cell Business to ReproCELL

BroadOak Partners advises Stemgent, a leader in developing innovative technology and application solutions that provide researchers the tools to investigate and understand cellular reprogramming, on the sale of its iPS Cell Business Unit to ReproCELL, Inc.

View Press Release.

Asuragen Sells Diagnostic Tests to PDI

BroadOak Partners advises Asuragen, a molecular diagnostics company, on the sale of its miRInform Thyroid™ and Pancreas tests to PDI, Inc.’s subsidiary, Interpace Diagnostics.

View Press Release.

EdgeBio Sells to StoneCalibre

BroadOak Partners advises Edge Biosystems, a specialized manufacturer and distributor of sample preparation and clean-up products for use in DNA sequencing, on its sale to StoneCalibre.

View Press Release.

BioCision Closes $4M Equity Financing and Signs Strategic Collaboration With Brooks Automation

BroadOak Partners advised BioCision in a strategic investment by Brooks Automation to accelerate commercial momentum.  In addition, the companies entered into a collaboration agreement to jointly develop products that support transport, storage and processing of biomaterials.

View Press Release.

ABL Sells Preclinical Services Business to BIOQUAL

BroadOak Partners advises Advanced Bioscience Laboratories (“ABL”), a leading life science contract research and manufacturing organization, on the sale of its in-vivo preclinical business to BIOQUAL, Inc.

Download Press Release.

EdgeBio Sells Sequencing Services Business to BioReference Laboratories

BroadOak Partners advises EdgeBio, a research reagents and sequencing services company, on the sale of its genetic sequencing services business to BioReference Laboratories, Inc.

Download Press Release.

SDIX Sells Life Science Business To OriGene Technologies

BroadOak Partners advises SDIX, an antibody focused biotechnology company, on the sale of the assets of its Life Science business to OriGene Technologies, Inc. for $16 million. BroadOak Partners also rendered a fairness opinion to the board of directors of SDIX.

Download Press Release.

UVP sells to Analytik Jena

BroadOak Partners advises UVP LLC on the sale of the company to Analytik Jena AG.  UVP is a leading developer and manufacturer of bioimaging systems and ultraviolet products for the academic, pharmaceutical and biotechnology markets and a portfolio company of Carlisle Enterprises.

Download Press Release.

SeraCare Life Sciences divests BioServices business

BroadOak Partners advises SeraCare Life Sciences, a diagnostics products company, on the sale of its BioServices business, a division which provides biorepository and sample handling services, to Precision Bioservices, Inc.

Download Press Release.

SDIX divests Food Safety and GMO businesses

BroadOak Partners advises SDIX, an antibody focused biotechnology company, on the sale of its Food Safety and GMO businesses to Romer Labs.

Download Press Release.

Carestream Health divests preclincial in-vivo imaging business

BroadOak Partners advises Carestream Health, Inc., a leader in healthcare imaging systems and films, on the sale of the in vivo business of Carestream Molecular Imaging, a division which provides preclinical imaging systems, to Bruker Corporation.

Download Press Release.

BioCision closes growth capital investment

BroadOak Capital Partners, through its affiliate the BroadOak Fund, participated in a financing for BioCision, LLC, a bench-top laboratory tools provider, to help fund the company’s growth.